APR. Geerts Charlotte SComm
APR. Geerts Charlotte reported total assets of 111,781 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).
The score of APR. Geerts Charlotte shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APR. Geerts Charlotte's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Mar 2026
- Year ended 31 Dec 2024filed on 09 May 2025
APR. Geerts Charlotte's financial analysis
- Solvency68.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APR. Geerts Charlotte
APR. Geerts Charlotte's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0822.177.245
- VAT number
- BE0822177245
- Peppol
- Registered · 0208:0822177245 · as of 10 Nov 2026
- Legal form
- SComm
- Incorporated
- 02 Jan 2010
- Registered office
- 2870 Puurs-Sint-Amands
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APR. Geerts Charlotte (SComm) has been based in Puurs-Sint-Amands since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,269 € and equity of 76,384 €; its revenue is not published. Its solvency stands at 68.3%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to APR. Geerts Charlotte
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie des Viaducs Retail sale of pharmaceutical products Mons · balance sheet 97,079 €
- Beisol Pharma Lubbeek Retail sale of pharmaceutical products Lubbeek · balance sheet 96,452 €
- BMVA Retail sale of pharmaceutical products Bornem · balance sheet 167,342 €
- Promeditech Retail sale of pharmaceutical products Brussels · balance sheet 186,985 €
- Apotheek Baert S. Retail sale of pharmaceutical products Bruges · balance sheet 194,387 €
- Sentelys Pharma Retail sale of pharmaceutical products Koekelberg · balance sheet 225,328 €
- Babay Pharma Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 246,996 €
- SOBEN Pharma Robeerst Retail sale of pharmaceutical products Esneux · balance sheet 282,954 €
Frequently asked questions about APR. Geerts Charlotte
What is the revenue of APR. Geerts Charlotte?
APR. Geerts Charlotte files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APR. Geerts Charlotte?
In Belgium, the VAT number is the company number prefixed with BE: BE0822177245 for APR. Geerts Charlotte, if the company is VAT-registered. Its company number (CBE) is 0822.177.245.
Where is the registered office of APR. Geerts Charlotte?
According to the CBE register, the registered office of APR. Geerts Charlotte is in 2870 Puurs-Sint-Amands.
What is the equity of APR. Geerts Charlotte?
At the close of the 2025 financial year, the equity of APR. Geerts Charlotte amounts to 76,384 €, a solvency of 68.3% of total assets.
Who manages APR. Geerts Charlotte?
The register lists 1 active mandates at APR. Geerts Charlotte. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APR. Geerts Charlotte
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →